You can also explore the broader Healthy Aging Supplements collection for related support
The clinical development program was discontinued due to insufficient weight loss efficacy rather than safety concerns
Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY
Water, Lcarnitine, acidity regulators citric acid and malic acid, lemon emulsion (aroma, colouring agent E-104 - may have an adverse effect on activity and attention in children), preservative potassium sorbate, D-calcium pantothenate (vitamin B5), preservative sodium benzoate, sweeteners acesulfame K and sucralose, pyridoxine hydrochloride (vitamin B6), sweetener steviol-glycosides
Pharmacokinetics (PK/PD): Half-life: Plasma half-life of systemic GHK-Cu is short, generally cited in external literature as 2 to 4 hours